Paysign, Inc. provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and ...
Paysign, Inc. (NASDAQ: PAYS) is a financial technology company founded in 2001 and headquartered in Henderson, Nevada. The company specializes in providing prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing solutions. Paysign serves a diverse clientele including corporations, municipalities, and government institutions, offering solutions ...Paysign, Inc. (NASDAQ: PAYS) is a financial technology company founded in 2001 and headquartered in Henderson, Nevada. The company specializes in providing prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing solutions. Paysign serves a diverse clientele including corporations, municipalities, and government institutions, offering solutions for corporate rewards, prepaid gift cards, general-purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement, and pharmaceutical payment assistance. The company also offers demand deposit accounts accessible via debit cards and software solutions. Paysign operates a customer service center and provides a communication suite including a mobile app, two-way SMS, text alerts, and a cardholder web portal. With over 20 years of experience, Paysign has issued over 3.1 million cards and provides physical and virtual card options. As of the latest data, Paysign has 26 full-time employees. Financially, Paysign generated revenue per share of $1.80, with a gross profit margin of 56.2% and a net profit margin of 15.7%. The company has a market capitalization of approximately $698 million, with a price-to-earnings ratio of 43.77. Paysign's key executive is co-founder, Chairman, President, and CEO Mark Newcomer, who has led the company since its inception. The company's products and services aim to solve complex payment problems for its clients, streamlining operations and improving client, employee, and partner loyalty. Paysign is not a bank; banking services are provided by partner banks such as Patriot Bank, N.A., Member FDIC, under a license from Visa. The company continues to innovate, as evidenced by its recent launch of the Paysign Premier referral program for digital banking solutions.
YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength.
QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes.
RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three).
$82.0M
+40.5%
+0.8%
Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day.
$7.6M
+97.9%
+24.2%
Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials.
+49.2%
-10.7%
+14.0%
Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on).
+8.8%
+404.7%
+4.3%
Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales.
+9.2%
+40.9%
+23.3%
Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock.
$51.2M
+280.7%
-105.9%
FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine.
+62.5%
+171.0%
-105.8%
Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe.
28.9%
+200.8%
-11.8%
Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking.
1.11x
+2.1%
+1.9%
Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground.
Operator: Good afternoon. My name is Kevin, and I'll be your conference operator today. At this time, I'd like to welcome everyone to Paysign, Inc.'s First Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. The comments on today's call regarding Paysign's financial results will be on a GAAP basis unless otherwise noted. Paysign's earnings release was disseminated to the SEC earlier today and can be found in the Investor Relations section of our website, paysign.com, which includes reconciliations of non-GAAP measures to GAAP reported amounts. Additionally, as set forth in more detail in our earnings release, I'd like to remind everyone that today's call will include forward-looking statements regarding Paysign's future performance. Actual performance could differ materially from these forward-looking statements. Information about the factors that could affect future performance is summarized at the end of Paysign's earnings release and in our section of SEC recent SEC filings. Lastly, a replay of this call will be available on August 12 -- until August 12, 2026. Please see Paysign's First Quarter 2026 earnings call announcement for details on how to access the replay. It's now my pleasure to turn the call over to Mr. Mark Newcomer, President and CEO. Please go ahead.
Mark Newcomer: Thank you, Kevin. Good afternoon, everyone, and thank you for joining us today for Paysign's First Quarter 2026 Earnings Call. I'm Mark Newcomer, President and Chief Executive Officer. Joining me today is Jeff Baker, our Chief Financial Officer. Also on the call are Matt Turner, our President of Patient Affordability; and Matt Lanford, our Chief Payments Officer, both of whom will be available for Q&A following our prepared remarks. Earlier today, we announced our first quarter financial results, which marked the strongest start to a year in Paysign's history. Revenue grew 50.8% to $28 million, exceeding the high end of guidance we provided in March. Net income increased 110% to $5.4 million and adjusted EBITDA increased 113% to $10.6 million. Most notably, operating margins increased 1,040 basis points or 10.4% year-over-year, demonstrating the operating leverage inherent in our business as we scale across health care and financial ecosystems. We continue to see strong growth across the patient affordability business in the first quarter. Revenue grew 82% year-over-year to $15.7 million, and claim volume was approximately 49% higher than Q1 2025, driven by a combination of new programs launched over the past year, organic growth within the existing programs and the continued ramp of our largest pharmaceutical clients. As expected, this rate reflects a larger and more established revenue base than a year ago. In Q1 alone, patient affordability generated nearly as much revenue as it did in the first half of 2025. During the quarter, our patient affordability business delivered more than $540 million in …